Financial Times FT.com

A bigger dose: Why generic drug producers are bulking up

By Andrew Jack

Published: July 22 2008 19:24 | Last updated: July 22 2008 19:24

Graphic

From his headquarters just outside Tel Aviv, Shlomo Yanai, a former top general in the Israeli Defence Force, is plotting the next stage in his commercial career: a campaign to reinforce his company Teva’s position as the world’s biggest generic medicines group.

You have viewed your allowance of free articles. If you wish to view more, click the button below.

Read this